Following HLA MM exposure, professional APCs, such as dendritic cells (DCs), macrophages, and B cells, can recognize HLA MM and engulf, process, and drive peptide degradation to further present determinant epitopes of donor HLA MMs to specific CD4 lymphocytes with MHC-II restriction [11]. Here, CD4 is linked to Miyoshi myopathy.